Mechanical heart valves offer better long-term survival for patients aged 50-70

Patients aged between 50 to 70 years with a mechanical heart valve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol has found.

‘This is censorship’: Trump freeze on communications forces medical journal to pull HHS authors’ article

An article that was written by U.S. Department of Health and Human Services employees and slated for publication in a medical journal this spring was

January 26, 2025

Marc Tessier-Lavigne steps down from Regeneron board

Marc Tessier-Lavigne stepped down from Regeneron’s board of directors. The move comes after he resigned as Stanford University’s president following a scientific misconduct investigation. Regeneron

September 12, 2023

Appeals court overturns Sutter Health’s victory in $400 million antitrust case

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for

June 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.